CDSCO approves HiMedia's latest COVID-19 testing products

January 31, 2022 | Monday | News

To encourage smaller labs that cannot afford high-end automation

Central Drugs Standard Control Organization (CDSCO) has approved two more important COVID-19 testing products of HiGenoMB – HiMedia Laboratories.

In the Hi-PCR COVID-19 Detection Kit-Dry Swab method (MBT189), the extraction free method assesses dry swab samples and supports direct real-time PCR post sample collection. This is an ideal solution to encourage smaller laboratories that cannot afford high-end automation and reduces dependency on skilled technicians to venture into molecular diagnostics.

The Hi-PCR COVID-19 Triplex Probe PCR Kit (MBPCR255) is a three gene multiplex PCR kit that can detect two target COVID genes, viz. (N) gene and RNA-dependent RNA polymerase (RdRp) gene along with an internal process control with maximum sensitivity. It is an alternative to our CDSCO approved four gene Hi-PCR Coronavirus (COVID-19) Probe PCR Kit (MBPCR243).

Visit www.himedialabs.com for more details about HiGenoMB® products related COVID Molecular testing.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy